HALOPERIDOL DOSE SYRINGE DRIVER

Sign Up Log In Cancel. Company contact details Janssen-Cilag Ltd. Caution is advised in patients with bradycardia, cardiac disease, family history of QTc prolongation or history of heavy alcohol exposure. Rare cases of sudden death have been reported in psychiatric patients receiving antipsychotics, including haloperidol see section 4. Extrapyramidal disorder Hyperkinesia Headache.

Uploader:	Julrajas
Date Added:	27 July 2007
File Size:	55.64 Mb
Operating Systems:	Windows NT/2000/XP/2003/2003/7/8/10 MacOS 10/X
Downloads:	43254
Price:	Free* [*Free Regsitration Required]

The main metabolic pathways of haloperidol in humans include glucuronidation, ketone reduction, oxidative N-dealkylation and formation of pyridinium metabolites.

Maximal enzyme induction is generally seen in about 2 weeks and may then be sustained for the same period of time after the cessation of therapy with the medicinal product.

Extrapyramidal symptoms Extrapyramidal symptoms may occur e. The risk of QTc prolongation increases with haloperidol dose and with haloperidol plasma concentrations. The major pathways are glucuronidation and ketone reduction. Therefore, dose adjustment and caution is advised in patients with hepatic impairment see sections 4.

Effect of haloperidol on other medicinal products Haloperidol can increase the CNS depression produced by alcohol or CNS-depressant medicinal products, including hypnotics, sedatives or strong analgesics.

It remains unclear whether this represents a distinct clinical entity. Enzyme dosw may be observed after a few days of treatment.

Haldol 2mg/ml oral solution - Summary of Product Characteristics (SmPC) - (eMC)

Results from small clinical studies suggest a lower clearance and a longer elimination half-life of haloperidol in elderly patients. Antagonism of the effect of the anticoagulant phenindione has been reported. haloperridol

Examples of medicinal products that may increase haloperidol plasma concentrations based on clinical experience or drug interaction mechanism include: Treatment of schizophrenia and schizoaffective disorder. If patients miss a dose, it is recommended that they take the next dose as usual, and do not take a double dose.

Consequently, it is recommended that newborn infants be monitored carefully. Haloperidol suppresses delusions and hallucinations as a direct consequence of haloperido dopaminergic syyringe in the mesolimbic pathway.

Haloperidol is an inhibitor of CYP2D6. The relevance of these tumour findings in rodents in terms of human risk is unknown. The risk of these events appears to increase with high doses, high plasma concentrations, in predisposed patients or with parenteral use, particularly intravenous administration.

Oculogyric crisis Visual disturbance. Tardive dyskinesia may appear in some patients on long-term therapy or after discontinuation of the medicinal product. Cerebrovascular events In randomised, placebo-controlled clinical studies in the dementia population, there was an approximately 3-fold increased risk of cerebrovascular adverse events dkse some atypical antipsychotics.

Haloperdol concentrations measured at various time points and after various durations of treatment, were either undetectable or ranged up to a maximum of Angioedema Dermatitis exfoliative Leukocytoclastic vasculitis.

Inappropriate antidiuretic hormone secretion. Haloperidol apparent clearance after extravascular administration ranges from 0.

Some degree of sedation or impairment of alertness may occur, particularly with higher doses and at the start of treatment and may be potentiated by alcohol. Analyses of seventeen placebo-controlled studies modal duration of 10 shringelargely in patients taking atypical antipsychotics, revealed a risk of death in treated patients of between 1.

Haldol 2mg/ml oral solution

Therefore, baseline and periodic electrolyte monitoring is recommended. The syndrome is mainly characterized by rhythmic involuntary movements of the tongue, face, mouth or jaw. The manifestations may be permanent in some patients. The activity on the basal ganglia probably underlies the undesirable extrapyramidal motor effects dystonia, akathisia and parkinsonism.

The central dopamine blocking effect has vose on the basal ganglia nigrostriatal bundles. Acute dystonia may necessitate stopping the medicinal product. Although no clear association with the administration of antipsychotics and human breast tumours has been demonstrated in clinical and epidemiological studies, caution is recommended in patients with relevant medical history. An extrapyramidal reaction is manifest by muscular rigidity and a generalised or localised tremor.